MEIP - 329K Reasons To Be Bullish On MEI Pharma Stock | Benzinga
Anson Funds Management LP, 10% Owner at MEI Pharma (NASDAQ:MEIP), reported a large insider buy on September 25, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that LP purchased 48,060 shares of MEI Pharma. The total transaction amounted to $329,331.
MEI Pharma shares are trading down 0.4% at $7.39 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, ...